Ampulla of Vater Adenosquamous Carcinoma
NCI Definition: A carcinoma with glandular and squamous differentiation arising from the ampulla of Vater. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. 
There is 1 clinical trial for ampulla of vater adenosquamous carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains ampulla of vater adenosquamous carcinoma as an inclusion criterion, 1 is phase 2 (1 open).
Retifanlimab is the most common intervention in ampulla of vater adenosquamous carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.